Furthermore, the advent of neprilysin inhibitors in clinical practice for the treatment of heart failure (these prevent the breakdown of BNP) makes NT‐proBNP a more reliable marker of natriuretic peptide levels so that BNP has gradually become less commonly measured. This evidence concerns the gene NPPB and heart failure.